Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Mar 14;3:CD004233. doi: 10.1002/14651858.CD004233.pub3
Methods RCT, DB single oral dose, 5 parallel groups
Medication administered when baseline pain reached a moderate to severe intensity
Pain assessed at 0, 15, 30, 45, 60, and 90 mins, then at 2, 3, 4, 5, 6, 7, 8, and 12 h
Participants Impacted third molar extraction
Mean age 22 years
N = 482
M = 124, F = 358
Interventions Celecoxib 400 mg, n = 151
Celecoxib 200 mg, n = 90
Rofecoxib 50 mg, n = 150
Ibuprofen 400 mg, n = 45
Placebo, n = 45
Outcomes PI: std 4-point scale
PR: std 5-point scale
PGE: std 5-point scale
Time to use of rescue medication
Number of participants using rescue medication
Notes Oxford Quality Score: R2, DB2, W1
Participants asked to refrain from rescue medication for 1.5 h
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Low risk “computer-generated allocation schedule”
Allocation concealment (selection bias) Low risk Participants allocated to next randomisation number (lowest for moderate pain, highest for severe pain)
Blinding (performance bias and detection bias)
All outcomes
Low risk Double-dummy method. Each active treatment had matching placebo tablets or capsules
Incomplete outcome data (attrition bias)
All outcomes
Low risk Participants accounted for; analysis appropriate for relevant time interval
Other bias High risk Small treatment group size (90 to 151 coxib, 45 to 50 ibuprofen, and placebo participants)